{
"info": {
"nct_id": "NCT01230866",
"official_title": "A Phase III Prospective Randomized Trial of Standard-fractionation vs. Hypo-fractionation With Proton Radiation Therapy for Low Risk Adenocarcinoma of the Prostate",
"inclusion_criteria": "* Histologically confirmed prostate adenocarcinoma within 365 days prior to randomization.\n* History/physical examination with digital rectal examination of the prostate and baseline toxicity assessment within 90 days prior to randomization.\n* Histological evaluation of prostate biopsy with assignment of a Gleason score to the biopsy material;Gleason score must be in the range of 2-6. > 6 cores are strongly recommended.\n* PSA values < 10 ng/ml within 90 days prior to randomization. Either done prior to biopsy or at least 21 days after prostate biopsy.\n* Clinical stages T1a-T2a N0 M0 (AJCC Criteria 7th Ed.). Staging must be done by treating investigator.\n* No pelvic lymph nodes > 1.5 cm in greatest dimension unless the enlarged lymph node is biopsied and negative.\n* Patients must be at least 18 years old.\n* ECOG performance status 0-1 (appendix I) documented within 90 days prior to randomization.\n* IPSS score <= 16.\n* Patients must give IRB approved, study specific, informed consent.\n* Patients must complete all mandatory tests listed in section 4.0 within the specified time frames.\n* Patients must be able to start treatment within 56 days of randomization.\nHealthy volunteers allowed\nMust be MALE\nMust have minimum age of 18 Years",
"exclusion_criteria": "* Previous prostate cancer surgery to include: prostatectomy, hyperthermia and cryosurgery.\n* Previous pelvic radiation for prostate cancer.\n* Androgen deprivation therapy prior to radiation is allowed. However, it is not acceptable if continued during radiation or as adjuvant therapy.\n* Active rectal diverticulitis, Crohn's disease affecting the rectum, or ulcerative colitis.\n* Prior systemic chemotherapy for prostate cancer.\n* History of proximal urethral stricture requiring dilatation.\n* Current and continuing anticoagulation with warfarin sodium (Coumadin, heparin, low-molecular weight heparin, Clopidogrel bisulfate (Plavix),or equivalent. (Unless it can be stopped to manage treatment related toxicity, to have a biopsy if needed, or for marker placement).\n* Any major medical, addictive or psychiatric illnesses which would affect the consent process, completion of treatment and/or interfere with follow-up. Consent by legal authorized representative is not permitted in this study.\n* Evidence of any other cancer within the past 5 years and < 50% probability of a 5 year survival. (Prior or concurrent diagnosis of basal cell or non-invasive squamous cell cancer of the skin is allowed).",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"identified_line": {
"line": "* Histologically confirmed prostate adenocarcinoma within 365 days prior to randomization.",
"criterions": [
{
"exact_snippets": "Histologically confirmed prostate adenocarcinoma",
"criterion": "prostate adenocarcinoma",
"requirement": {
"requirement_type": "confirmation method",
"expected_value": "histologically confirmed"
}
},
{
"exact_snippets": "within 365 days prior to randomization",
"criterion": "diagnosis timing",
"requirement": {
"requirement_type": "time frame",
"expected_value": {
"operator": "<=",
"value": 365,
"unit": "days"
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Histologically confirmed prostate adenocarcinoma",
"criterion": "prostate adenocarcinoma",
"requirement": {
"requirement_type": "confirmation method",
"expected_value": "histologically confirmed"
}
},
{
"exact_snippets": "within 365 days prior to randomization",
"criterion": "diagnosis timing",
"requirement": {
"requirement_type": "time frame",
"expected_value": {
"operator": "<=",
"value": 365,
"unit": "days"
}
}
}
]
}
},
{
"identified_line": {
"line": "* History/physical examination with digital rectal examination of the prostate and baseline toxicity assessment within 90 days prior to randomization.",
"criterions": [
{
"exact_snippets": "History/physical examination",
"criterion": "history and physical examination",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "digital rectal examination of the prostate",
"criterion": "digital rectal examination of the prostate",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "baseline toxicity assessment",
"criterion": "baseline toxicity assessment",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "within 90 days prior to randomization",
"criterion": "timeframe for assessments",
"requirement": {
"requirement_type": "timeframe",
"expected_value": {
"operator": "<=",
"value": 90,
"unit": "days"
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"and_criteria": [
{
"and_criteria": [
{
"exact_snippets": "History/physical examination",
"criterion": "history and physical examination",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "digital rectal examination of the prostate",
"criterion": "digital rectal examination of the prostate",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
},
{
"exact_snippets": "baseline toxicity assessment",
"criterion": "baseline toxicity assessment",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
},
{
"exact_snippets": "within 90 days prior to randomization",
"criterion": "timeframe for assessments",
"requirement": {
"requirement_type": "timeframe",
"expected_value": {
"operator": "<=",
"value": 90,
"unit": "days"
}
}
}
]
}
},
{
"identified_line": {
"line": "* Histological evaluation of prostate biopsy with assignment of a Gleason score to the biopsy material;Gleason score must be in the range of 2-6. > 6 cores are strongly recommended.",
"criterions": [
{
"exact_snippets": "Histological evaluation of prostate biopsy",
"criterion": "prostate biopsy",
"requirement": {
"requirement_type": "evaluation",
"expected_value": "histological"
}
},
{
"exact_snippets": "assignment of a Gleason score to the biopsy material",
"criterion": "Gleason score",
"requirement": {
"requirement_type": "assignment",
"expected_value": "to biopsy material"
}
},
{
"exact_snippets": "Gleason score must be in the range of 2-6",
"criterion": "Gleason score",
"requirement": {
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 2,
"unit": "N/A"
},
{
"operator": "<=",
"value": 6,
"unit": "N/A"
}
]
}
}
},
{
"exact_snippets": "> 6 cores are strongly recommended",
"criterion": "biopsy cores",
"requirement": {
"requirement_type": "quantity",
"expected_value": {
"operator": ">",
"value": 6,
"unit": "cores"
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"and_criteria": [
{
"exact_snippets": "Histological evaluation of prostate biopsy",
"criterion": "prostate biopsy",
"requirement": {
"requirement_type": "evaluation",
"expected_value": "histological"
}
},
{
"exact_snippets": "assignment of a Gleason score to the biopsy material",
"criterion": "Gleason score",
"requirement": {
"requirement_type": "assignment",
"expected_value": "to biopsy material"
}
},
{
"exact_snippets": "Gleason score must be in the range of 2-6",
"criterion": "Gleason score",
"requirement": {
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 2,
"unit": "N/A"
},
{
"operator": "<=",
"value": 6,
"unit": "N/A"
}
]
}
}
}
]
},
{
"exact_snippets": "> 6 cores are strongly recommended",
"criterion": "biopsy cores",
"requirement": {
"requirement_type": "quantity",
"expected_value": {
"operator": ">",
"value": 6,
"unit": "cores"
}
}
}
]
}
},
{
"identified_line": {
"line": "* Clinical stages T1a-T2a N0 M0 (AJCC Criteria 7th Ed.). Staging must be done by treating investigator.",
"criterions": [
{
"exact_snippets": "Clinical stages T1a-T2a N0 M0 (AJCC Criteria 7th Ed.)",
"criterion": "clinical stage",
"requirement": {
"requirement_type": "range",
"expected_value": [
"T1a",
"T2a"
]
}
},
{
"exact_snippets": "Clinical stages T1a-T2a N0 M0 (AJCC Criteria 7th Ed.)",
"criterion": "nodal involvement",
"requirement": {
"requirement_type": "presence",
"expected_value": "N0"
}
},
{
"exact_snippets": "Clinical stages T1a-T2a N0 M0 (AJCC Criteria 7th Ed.)",
"criterion": "metastasis",
"requirement": {
"requirement_type": "presence",
"expected_value": "M0"
}
},
{
"exact_snippets": "Staging must be done by treating investigator",
"criterion": "staging responsibility",
"requirement": {
"requirement_type": "responsibility",
"expected_value": "treating investigator"
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"and_criteria": [
{
"and_criteria": [
{
"exact_snippets": "Clinical stages T1a-T2a N0 M0 (AJCC Criteria 7th Ed.)",
"criterion": "clinical stage",
"requirement": {
"requirement_type": "range",
"expected_value": [
"T1a",
"T2a"
]
}
},
{
"exact_snippets": "Clinical stages T1a-T2a N0 M0 (AJCC Criteria 7th Ed.)",
"criterion": "nodal involvement",
"requirement": {
"requirement_type": "presence",
"expected_value": "N0"
}
}
]
},
{
"exact_snippets": "Clinical stages T1a-T2a N0 M0 (AJCC Criteria 7th Ed.)",
"criterion": "metastasis",
"requirement": {
"requirement_type": "presence",
"expected_value": "M0"
}
}
]
},
{
"exact_snippets": "Staging must be done by treating investigator",
"criterion": "staging responsibility",
"requirement": {
"requirement_type": "responsibility",
"expected_value": "treating investigator"
}
}
]
}
},
{
"identified_line": {
"line": "* No pelvic lymph nodes > 1.5 cm in greatest dimension unless the enlarged lymph node is biopsied and negative.",
"criterions": [
{
"exact_snippets": "pelvic lymph nodes > 1.5 cm in greatest dimension",
"criterion": "pelvic lymph nodes",
"requirement": {
"requirement_type": "size",
"expected_value": {
"operator": ">",
"value": 1.5,
"unit": "cm"
}
}
},
{
"exact_snippets": "unless the enlarged lymph node is biopsied and negative",
"criterion": "enlarged lymph node biopsy",
"requirement": {
"requirement_type": "result",
"expected_value": "negative"
}
}
]
},
"logical_structure": {
"condition": {
"and_criteria": [
{
"exact_snippets": "pelvic lymph nodes > 1.5 cm in greatest dimension",
"criterion": "pelvic lymph nodes",
"requirement": {
"requirement_type": "size",
"expected_value": {
"operator": ">",
"value": 1.5,
"unit": "cm"
}
}
}
]
},
"then_criteria": {
"exact_snippets": "unless the enlarged lymph node is biopsied and negative",
"criterion": "enlarged lymph node biopsy",
"requirement": {
"requirement_type": "result",
"expected_value": "negative"
}
},
"else_criteria": null
}
},
{
"identified_line": {
"line": "* Patients must be at least 18 years old.",
"criterions": [
{
"exact_snippets": "Patients must be at least 18 years old.",
"criterion": "age",
"requirement": {
"requirement_type": "minimum age",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "years"
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Patients must be at least 18 years old.",
"criterion": "age",
"requirement": {
"requirement_type": "minimum age",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "years"
}
}
}
]
}
},
{
"identified_line": {
"line": "* ECOG performance status 0-1 (appendix I) documented within 90 days prior to randomization.",
"criterions": [
{
"exact_snippets": "ECOG performance status 0-1",
"criterion": "ECOG performance status",
"requirement": {
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 0,
"unit": "N/A"
},
{
"operator": "<=",
"value": 1,
"unit": "N/A"
}
]
}
}
},
{
"exact_snippets": "documented within 90 days prior to randomization",
"criterion": "documentation of ECOG performance status",
"requirement": {
"requirement_type": "timeframe",
"expected_value": "within 90 days prior to randomization"
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "ECOG performance status 0-1",
"criterion": "ECOG performance status",
"requirement": {
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 0,
"unit": "N/A"
},
{
"operator": "<=",
"value": 1,
"unit": "N/A"
}
]
}
}
},
{
"exact_snippets": "documented within 90 days prior to randomization",
"criterion": "documentation of ECOG performance status",
"requirement": {
"requirement_type": "timeframe",
"expected_value": "within 90 days prior to randomization"
}
}
]
}
},
{
"identified_line": {
"line": "* IPSS score <= 16.",
"criterions": [
{
"exact_snippets": "IPSS score <= 16",
"criterion": "IPSS score",
"requirement": {
"requirement_type": "value",
"expected_value": {
"operator": "<=",
"value": 16,
"unit": "N/A"
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "IPSS score <= 16",
"criterion": "IPSS score",
"requirement": {
"requirement_type": "value",
"expected_value": {
"operator": "<=",
"value": 16,
"unit": "N/A"
}
}
}
]
}
},
{
"identified_line": {
"line": "* Patients must give IRB approved, study specific, informed consent.",
"criterions": [
{
"exact_snippets": "Patients must give IRB approved, study specific, informed consent.",
"criterion": "informed consent",
"requirement": {
"requirement_type": "approval",
"expected_value": "IRB approved"
}
},
{
"exact_snippets": "Patients must give IRB approved, study specific, informed consent.",
"criterion": "informed consent",
"requirement": {
"requirement_type": "specificity",
"expected_value": "study specific"
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Patients must give IRB approved, study specific, informed consent.",
"criterion": "informed consent",
"requirement": {
"requirement_type": "approval",
"expected_value": "IRB approved"
}
},
{
"exact_snippets": "Patients must give IRB approved, study specific, informed consent.",
"criterion": "informed consent",
"requirement": {
"requirement_type": "specificity",
"expected_value": "study specific"
}
}
]
}
},
{
"identified_line": {
"line": "* Patients must complete all mandatory tests listed in section 4.0 within the specified time frames.",
"criterions": [
{
"exact_snippets": "complete all mandatory tests",
"criterion": "mandatory tests",
"requirement": {
"requirement_type": "completion",
"expected_value": true
}
},
{
"exact_snippets": "within the specified time frames",
"criterion": "time frames for tests",
"requirement": {
"requirement_type": "adherence",
"expected_value": "specified time frames"
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "complete all mandatory tests",
"criterion": "mandatory tests",
"requirement": {
"requirement_type": "completion",
"expected_value": true
}
},
{
"exact_snippets": "within the specified time frames",
"criterion": "time frames for tests",
"requirement": {
"requirement_type": "adherence",
"expected_value": "specified time frames"
}
}
]
}
},
{
"identified_line": {
"line": "* Patients must be able to start treatment within 56 days of randomization.",
"criterions": [
{
"exact_snippets": "Patients must be able to start treatment within 56 days of randomization.",
"criterion": "treatment start time",
"requirement": {
"requirement_type": "time frame",
"expected_value": {
"operator": "<=",
"value": 56,
"unit": "days"
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Patients must be able to start treatment within 56 days of randomization.",
"criterion": "treatment start time",
"requirement": {
"requirement_type": "time frame",
"expected_value": {
"operator": "<=",
"value": 56,
"unit": "days"
}
}
}
]
}
},
{
"identified_line": {
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirement": {
"requirement_type": "status",
"expected_value": "healthy"
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirement": {
"requirement_type": "status",
"expected_value": "healthy"
}
}
]
}
},
{
"identified_line": {
"line": "Must be MALE",
"criterions": [
{
"exact_snippets": "MALE",
"criterion": "gender",
"requirement": {
"requirement_type": "expected_value",
"expected_value": "male"
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "MALE",
"criterion": "gender",
"requirement": {
"requirement_type": "expected_value",
"expected_value": "male"
}
}
]
}
},
{
"identified_line": {
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirement": {
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirement": {
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
}
]
}
}
],
"exclusion_lines": [
{
"identified_line": {
"line": "* Previous prostate cancer surgery to include: prostatectomy, hyperthermia and cryosurgery.",
"criterions": [
{
"exact_snippets": "Previous prostate cancer surgery to include: prostatectomy",
"criterion": "previous prostate cancer surgery",
"requirement": {
"requirement_type": "type",
"expected_value": "prostatectomy"
}
},
{
"exact_snippets": "Previous prostate cancer surgery to include: ... hyperthermia",
"criterion": "previous prostate cancer surgery",
"requirement": {
"requirement_type": "type",
"expected_value": "hyperthermia"
}
},
{
"exact_snippets": "Previous prostate cancer surgery to include: ... cryosurgery",
"criterion": "previous prostate cancer surgery",
"requirement": {
"requirement_type": "type",
"expected_value": "cryosurgery"
}
}
]
},
"logical_structure": {
"or_criteria": [
{
"exact_snippets": "Previous prostate cancer surgery to include: prostatectomy",
"criterion": "previous prostate cancer surgery",
"requirement": {
"requirement_type": "type",
"expected_value": "prostatectomy"
}
},
{
"exact_snippets": "Previous prostate cancer surgery to include: ... hyperthermia",
"criterion": "previous prostate cancer surgery",
"requirement": {
"requirement_type": "type",
"expected_value": "hyperthermia"
}
},
{
"exact_snippets": "Previous prostate cancer surgery to include: ... cryosurgery",
"criterion": "previous prostate cancer surgery",
"requirement": {
"requirement_type": "type",
"expected_value": "cryosurgery"
}
}
]
}
},
{
"identified_line": {
"line": "* Previous pelvic radiation for prostate cancer.",
"criterions": [
{
"exact_snippets": "Previous pelvic radiation for prostate cancer.",
"criterion": "pelvic radiation",
"requirement": {
"requirement_type": "history",
"expected_value": true
}
},
{
"exact_snippets": "Previous pelvic radiation for prostate cancer.",
"criterion": "prostate cancer",
"requirement": {
"requirement_type": "history",
"expected_value": true
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Previous pelvic radiation for prostate cancer.",
"criterion": "pelvic radiation",
"requirement": {
"requirement_type": "history",
"expected_value": true
}
},
{
"exact_snippets": "Previous pelvic radiation for prostate cancer.",
"criterion": "prostate cancer",
"requirement": {
"requirement_type": "history",
"expected_value": true
}
}
]
}
},
{
"identified_line": {
"line": "* Androgen deprivation therapy prior to radiation is allowed. However, it is not acceptable if continued during radiation or as adjuvant therapy.",
"criterions": [
{
"exact_snippets": "Androgen deprivation therapy prior to radiation is allowed",
"criterion": "androgen deprivation therapy",
"requirement": {
"requirement_type": "timing",
"expected_value": "prior to radiation"
}
},
{
"exact_snippets": "it is not acceptable if continued during radiation",
"criterion": "androgen deprivation therapy",
"requirement": {
"requirement_type": "timing",
"expected_value": "not during radiation"
}
},
{
"exact_snippets": "it is not acceptable if continued ... as adjuvant therapy",
"criterion": "androgen deprivation therapy",
"requirement": {
"requirement_type": "timing",
"expected_value": "not as adjuvant therapy"
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"or_criteria": [
{
"and_criteria": [
{
"exact_snippets": "Androgen deprivation therapy prior to radiation is allowed",
"criterion": "androgen deprivation therapy",
"requirement": {
"requirement_type": "timing",
"expected_value": "prior to radiation"
}
},
{
"exact_snippets": "it is not acceptable if continued during radiation",
"criterion": "androgen deprivation therapy",
"requirement": {
"requirement_type": "timing",
"expected_value": "not during radiation"
}
}
]
},
{
"and_criteria": [
{
"exact_snippets": "Androgen deprivation therapy prior to radiation is allowed",
"criterion": "androgen deprivation therapy",
"requirement": {
"requirement_type": "timing",
"expected_value": "prior to radiation"
}
},
{
"exact_snippets": "it is not acceptable if continued ... as adjuvant therapy",
"criterion": "androgen deprivation therapy",
"requirement": {
"requirement_type": "timing",
"expected_value": "not as adjuvant therapy"
}
}
]
}
]
}
]
}
},
{
"identified_line": {
"line": "* Active rectal diverticulitis, Crohn's disease affecting the rectum, or ulcerative colitis.",
"criterions": [
{
"exact_snippets": "Active rectal diverticulitis",
"criterion": "rectal diverticulitis",
"requirement": {
"requirement_type": "activity",
"expected_value": "active"
}
},
{
"exact_snippets": "Crohn's disease affecting the rectum",
"criterion": "Crohn's disease",
"requirement": {
"requirement_type": "location",
"expected_value": "rectum"
}
},
{
"exact_snippets": "ulcerative colitis",
"criterion": "ulcerative colitis",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
},
"logical_structure": {
"or_criteria": [
{
"and_criteria": [
{
"exact_snippets": "Active rectal diverticulitis",
"criterion": "rectal diverticulitis",
"requirement": {
"requirement_type": "activity",
"expected_value": "active"
}
}
]
},
{
"and_criteria": [
{
"exact_snippets": "Crohn's disease affecting the rectum",
"criterion": "Crohn's disease",
"requirement": {
"requirement_type": "location",
"expected_value": "rectum"
}
}
]
},
{
"and_criteria": [
{
"exact_snippets": "ulcerative colitis",
"criterion": "ulcerative colitis",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
}
]
}
},
{
"identified_line": {
"line": "* History of proximal urethral stricture requiring dilatation.",
"criterions": [
{
"exact_snippets": "History of proximal urethral stricture",
"criterion": "proximal urethral stricture",
"requirement": {
"requirement_type": "history",
"expected_value": true
}
},
{
"exact_snippets": "requiring dilatation",
"criterion": "dilatation",
"requirement": {
"requirement_type": "necessity",
"expected_value": true
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "History of proximal urethral stricture",
"criterion": "proximal urethral stricture",
"requirement": {
"requirement_type": "history",
"expected_value": true
}
},
{
"exact_snippets": "requiring dilatation",
"criterion": "dilatation",
"requirement": {
"requirement_type": "necessity",
"expected_value": true
}
}
]
}
},
{
"identified_line": {
"line": "* Current and continuing anticoagulation with warfarin sodium (Coumadin, heparin, low-molecular weight heparin, Clopidogrel bisulfate (Plavix),or equivalent. (Unless it can be stopped to manage treatment related toxicity, to have a biopsy if needed, or for marker placement).",
"criterions": [
{
"exact_snippets": "Current and continuing anticoagulation with warfarin sodium (Coumadin, heparin, low-molecular weight heparin, Clopidogrel bisulfate (Plavix),or equivalent.",
"criterion": "anticoagulation",
"requirement": {
"requirement_type": "medication",
"expected_value": [
"warfarin sodium",
"heparin",
"low-molecular weight heparin",
"Clopidogrel bisulfate",
"equivalent"
]
}
},
{
"exact_snippets": "Current and continuing anticoagulation with warfarin sodium (Coumadin, heparin, low-molecular weight heparin, Clopidogrel bisulfate (Plavix),or equivalent.",
"criterion": "anticoagulation",
"requirement": {
"requirement_type": "status",
"expected_value": "current and continuing"
}
}
]
},
"logical_structure": {
"condition": {
"and_criteria": [
{
"exact_snippets": "Current and continuing anticoagulation with warfarin sodium (Coumadin, heparin, low-molecular weight heparin, Clopidogrel bisulfate (Plavix),or equivalent.",
"criterion": "anticoagulation",
"requirement": {
"requirement_type": "medication",
"expected_value": [
"warfarin sodium",
"heparin",
"low-molecular weight heparin",
"Clopidogrel bisulfate",
"equivalent"
]
}
},
{
"exact_snippets": "Current and continuing anticoagulation with warfarin sodium (Coumadin, heparin, low-molecular weight heparin, Clopidogrel bisulfate (Plavix),or equivalent.",
"criterion": "anticoagulation",
"requirement": {
"requirement_type": "status",
"expected_value": "current and continuing"
}
}
]
},
"then_criteria": {
"not_criteria": {
"exact_snippets": "Unless it can be stopped to manage treatment related toxicity, to have a biopsy if needed, or for marker placement.",
"criterion": "anticoagulation stoppage",
"requirement": {
"requirement_type": "possibility",
"expected_value": true
}
}
},
"else_criteria": null
}
},
{
"identified_line": {
"line": "* Any major medical, addictive or psychiatric illnesses which would affect the consent process, completion of treatment and/or interfere with follow-up. Consent by legal authorized representative is not permitted in this study.",
"criterions": [
{
"exact_snippets": "major medical, addictive or psychiatric illnesses",
"criterion": "medical, addictive or psychiatric illnesses",
"requirement": {
"requirement_type": "severity",
"expected_value": "major"
}
},
{
"exact_snippets": "Consent by legal authorized representative is not permitted",
"criterion": "consent by legal authorized representative",
"requirement": {
"requirement_type": "permission",
"expected_value": false
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"or_criteria": [
{
"and_criteria": [
{
"exact_snippets": "major medical, addictive or psychiatric illnesses",
"criterion": "medical, addictive or psychiatric illnesses",
"requirement": {
"requirement_type": "severity",
"expected_value": "major"
}
},
{
"or_criteria": [
{
"exact_snippets": "major medical, addictive or psychiatric illnesses",
"criterion": "medical, addictive or psychiatric illnesses",
"requirement": {
"requirement_type": "affect on consent process",
"expected_value": true
}
},
{
"exact_snippets": "major medical, addictive or psychiatric illnesses",
"criterion": "medical, addictive or psychiatric illnesses",
"requirement": {
"requirement_type": "affect on completion of treatment",
"expected_value": true
}
},
{
"exact_snippets": "major medical, addictive or psychiatric illnesses",
"criterion": "medical, addictive or psychiatric illnesses",
"requirement": {
"requirement_type": "interfere with follow-up",
"expected_value": true
}
}
]
}
]
},
{
"exact_snippets": "Consent by legal authorized representative is not permitted",
"criterion": "consent by legal authorized representative",
"requirement": {
"requirement_type": "permission",
"expected_value": false
}
}
]
}
]
}
}
],
"miscellaneous_lines": [],
"failed_inclusion": [
{
"identified_line": {
"line": "* PSA values < 10 ng/ml within 90 days prior to randomization. Either done prior to biopsy or at least 21 days after prostate biopsy.",
"criterions": [
{
"exact_snippets": "PSA values < 10 ng/ml",
"criterion": "PSA values",
"requirement": {
"requirement_type": "value",
"expected_value": {
"operator": "<",
"value": 10,
"unit": "ng/ml"
}
}
},
{
"exact_snippets": "within 90 days prior to randomization",
"criterion": "PSA test timing",
"requirement": {
"requirement_type": "timing",
"expected_value": "within 90 days prior to randomization"
}
},
{
"exact_snippets": "Either done prior to biopsy or at least 21 days after prostate biopsy",
"criterion": "PSA test timing relative to biopsy",
"requirement": {
"requirement_type": "timing",
"expected_value": [
"prior to biopsy",
"at least 21 days after prostate biopsy"
]
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"and_criteria": [
{
"exact_snippets": "PSA values < 10 ng/ml",
"criterion": "PSA values",
"requirement": {
"requirement_type": "value",
"expected_value": {
"operator": "<",
"value": 10,
"unit": "ng/ml"
}
}
},
{
"exact_snippets": "within 90 days prior to randomization",
"criterion": "PSA test timing",
"requirement": {
"requirement_type": "timing",
"expected_value": "within 90 days prior to randomization"
}
}
]
},
{
"or_criteria": [
{
"exact_snippets": "Either done prior to biopsy or at least 21 days after prostate biopsy",
"criterion": "PSA test timing relative to biopsy",
"requirement": {
"requirement_type": "timing",
"expected_value": "prior to biopsy"
}
},
{
"exact_snippets": "Either done prior to biopsy or at least 21 days after prostate biopsy",
"criterion": "PSA test timing relative to biopsy",
"requirement": {
"requirement_type": "timing",
"expected_value": "at least 21 days after prostate biopsy"
}
}
]
}
]
}
}
],
"failed_exclusion": [
{
"identified_line": {
"line": "* Prior systemic chemotherapy for prostate cancer.",
"criterions": [
{
"exact_snippets": "Prior systemic chemotherapy for prostate cancer",
"criterion": "systemic chemotherapy",
"requirement": {
"requirement_type": "prior treatment",
"expected_value": true
}
}
]
},
"logical_structure": {
"exact_snippets": "failed",
"criterion": "failed",
"requirement": {
"requirement_type": "failed",
"expected_value": "failed"
}
}
},
{
"identified_line": {
"line": "* Evidence of any other cancer within the past 5 years and < 50% probability of a 5 year survival. (Prior or concurrent diagnosis of basal cell or non-invasive squamous cell cancer of the skin is allowed).",
"criterions": [
{
"exact_snippets": "Evidence of any other cancer within the past 5 years",
"criterion": "other cancer",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "Evidence of any other cancer within the past 5 years",
"criterion": "other cancer",
"requirement": {
"requirement_type": "time frame",
"expected_value": {
"operator": "<=",
"value": 5,
"unit": "years"
}
}
},
{
"exact_snippets": "< 50% probability of a 5 year survival",
"criterion": "5 year survival probability",
"requirement": {
"requirement_type": "probability",
"expected_value": {
"operator": "<",
"value": 50,
"unit": "%"
}
}
},
{
"exact_snippets": "Prior or concurrent diagnosis of basal cell or non-invasive squamous cell cancer of the skin is allowed",
"criterion": "basal cell or non-invasive squamous cell cancer of the skin",
"requirement": {
"requirement_type": "diagnosis",
"expected_value": true
}
}
]
},
"logical_structure": {
"exact_snippets": "failed",
"criterion": "failed",
"requirement": {
"requirement_type": "failed",
"expected_value": "failed"
}
}
}
],
"failed_miscellaneous": []
}